Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials

To assess the association of the vitreomacular interface with outcomes of eyes treated with anti-vascular endothelial growth factor drugs for neovascular age-related macular degeneration (AMD). Prospective cohort study within a multicenter, randomized clinical trial. Patients enrolled in the Compari...

Full description

Saved in:

Bibliographic Details
Published in:	Ophthalmology (Rochester, Minn.) Vol. 122; no. 6; p. 1203
Main Authors:	Ciulla, Thomas A, Cuilla, Thomas A, Ying, Gui-Shuang, Maguire, Maureen G, Martin, Daniel F, Jaffe, Glenn J, Grunwald, Juan E, Daniel, Ebenezer, Toth, Cynthia A
Format:	Journal Article
Language:	English
Published:	United States 01.06.2015
Subjects:	Aged Aged, 80 and over Angiogenesis Inhibitors - administration & dosage Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - therapeutic use Bevacizumab Blood-Retinal Barrier Cohort Studies Female Fluorescein Angiography Humans Intravitreal Injections Macula Lutea - pathology Male Prospective Studies Ranibizumab Retinal Diseases - complications Subretinal Fluid Tissue Adhesions Tomography, Optical Coherence Treatment Outcome Vascular Endothelial Growth Factor A - antagonists & inhibitors Visual Acuity - physiology Vitreous Body - pathology Wet Macular Degeneration - diagnosis Wet Macular Degeneration - drug therapy Wet Macular Degeneration - physiopathology
ISSN:	1549-4713, 1549-4713
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!